Madrigal Pharmaceuticals (MDGL) Enterprise Value Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Madrigal Pharmaceuticals | 14.44 Bn | 14.20 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.45% |
| Dec 31, 2025 | 6.43% |
| Sep 30, 2025 | -27.00% |
| Jun 30, 2025 | -15.70% |
| Mar 31, 2025 | -15.59% |
| Dec 31, 2024 | 24.88% |
| Sep 30, 2024 | -17.10% |
| Jun 30, 2024 | -17.80% |
| Mar 31, 2024 | -17.25% |
| Dec 31, 2023 | 27.05% |
| Sep 30, 2023 | 13.81% |
| Jun 30, 2023 | 9.45% |
| Mar 31, 2023 | -12.50% |
| Dec 31, 2022 | -13.38% |
| Sep 30, 2022 | -19.78% |
| Jun 30, 2022 | -25.82% |
| Mar 31, 2022 | -40.53% |
| Dec 31, 2021 | -46.18% |
| Sep 30, 2021 | -49.88% |
| Jun 30, 2021 | -54.87% |
| Mar 31, 2021 | -99.00% |
| Dec 31, 2020 | -54.85% |
| Sep 30, 2020 | -51.02% |
| Jun 30, 2020 | -31.34% |
| Mar 31, 2020 | -39.76% |
| Dec 31, 2019 | -53.32% |
| Sep 30, 2019 | -30.62% |
| Jun 30, 2019 | -33.00% |
| Mar 31, 2019 | -43.40% |
| Dec 31, 2018 | -39.53% |
| Sep 30, 2018 | -55.70% |
| Jun 30, 2018 | -47.51% |
| Mar 31, 2018 | -15.13% |
| Dec 31, 2017 | -13.74% |
| Sep 30, 2017 | -2.42% |
| Jun 30, 2017 | -8.51% |
| Mar 31, 2017 | 6.91% |
| Dec 31, 2016 | -0.39% |
| Sep 30, 2016 | 4.83% |
| Jun 30, 2016 | 10.38% |
| Mar 31, 2016 | 10.74% |
| Dec 31, 2015 | 8.94% |
| Sep 30, 2015 | -4.15% |
| Jun 30, 2015 | -18.21% |